“clinical-trials” Archives

in
Entry Author Date Location
As Key Data Loom, Nobel Winner Mello Reflects on RNAi “Sci-Fi” Story 09/06/17 Boston
Patient Death Triggers FDA Hold For Cellectis’s “Off the Shelf” CAR-T 09/05/17 New York
Eli Lilly Preps Rejected Rheumatoid Arthritis Drug for Resubmission 08/30/17 Indiana
Otonomy Scraps Hearing Loss Drug After Phase 3 Flop, Shares Routed 08/30/17 San Diego
Celgene Broadens Forma Deal, Adding $195M More for Drug R&D 08/29/17 New York
Jazz Pharma, ImmunoGen Strike Up Drug Pact in Leukemia and More 08/29/17 Boston
Will Merck Seek FDA Filing For Heart Drug After Lackluster Results? 08/29/17 New York
FDA Refuses to Review Acorda Parkinson’s Drug, Shares Tumble 08/29/17 New York
SetPoint Nabs $30M For More Tests of Bioelectric Device as RA Therapy 08/28/17 San Francisco
Gilead Makes Long-Awaited Splash With $12B Bet on Kite, Cell Therapy 08/28/17 San Francisco
RegenxBio to Acquire Dimension Tx in Combo of Gene Therapy Companies 08/25/17 Boston
Bio Roundup: Drug Price Debates, NY Bio Blooms & CEOs Take Social Stand 08/25/17 National
FDA Clears Way for Filing on Psych Drug From Intra-Cellular, Shares Climb 08/23/17 New York
Alzeca Receives $11M for Early Alzheimer’s Detection Technology 08/17/17 Texas
Novo Nordisk Diabetes Drug Beats Lilly’s Trulicity in Head-to-Head Test 08/17/17 Indiana
Latest Immunotherapy Setback: Bristol Drugs Stumble in Kidney Cancer 08/16/17 New York
Ophthotech’s Final Try at Combo Eye Drug Comes up Short 08/14/17 New York
GSK Hands Nerve Drug Back to Ionis as RNA Battle Heats Up 08/11/17 San Diego
Antibiotics Firms Cempra, Melinta Therapeutics Agree to Merger 08/09/17 Raleigh Durham
Dermira Commits $135M for Global Rights to Roche Eczema Drug 08/08/17 San Francisco
MyoKardia Heart Drug Boosts Blood Flow, Sends Shares Soaring 08/07/17 San Francisco
Houston Biotech Oncolix Announces Reverse Merger, Goes Public 08/07/17 Texas
Robot Startup Auris Reels In $280M for Less Invasive Lung Surgery 08/04/17 San Francisco
Fresh Off New Funding Round, FluGen Plans 3 Clinical Trials for 2018 08/04/17 Wisconsin
Mattessich Starts as New Ocular CEO, Trims Staff in Cost-Saving Move 08/02/17 Boston
With FDA Nod, Agios, Celgene Get Speedy OK For Blood Cancer Drug 08/01/17 Boston
Homology Med Bags $83.5M More, Fueling Push For Gene Editing Twist 08/01/17 Boston
Immunotherapy Shakeup: AstraZeneca Inks Merck Deal as Drug Combo Fails 07/27/17 National
Tetraphase Claws Back From Failed Study, Eyes FDA Filing With New Data 07/26/17 Boston
Eli Lilly Pays Nektar $150M Up Front For Autoimmune Drug Rights 07/24/17 Indiana
Page 3 of 28 « previous page · next page »